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Seminalplasmin (SPLN), a 47-residue peptide pres- 
ent in bovine seminal plasma, is one of the few proteins 
isolated from mammalian sources having potent anti- 
bacterial activity. SPLN also interacts with sperm ac- 
rosomal and plasma membranes. On the basis of analy- 
sis of the primary structure of SPLN with respect to 
its relative hydrophobicity and hydrophilicity, a region 
comprising of 13-amino acids, Pro-Lys-Leu-Leu-Glu- 
Thr-Phe-Leu-Ser-Lys-Trp-Ile-Gly, has been deline- 
ated. It is demonstrated that a synthetic peptide cor- 
responding to this 13-residue region inhibits growth 
of Escherichia coli like SPLN and also has the ability 
to lyse red blood cells. 
A large number of peptides comprising approximately 15- 
40 residues, isolated from diverse sources such as insect venom 
(1, 2) and insect hemolymph (3) have potent antibacterial 
activity. Many of these peptides also exhibit lytic activity 
against eukaryotic cells (1, 4, 5). The biological activity of 
these peptides stem from their ability to spontaneously par- 
tition into the lipid bilayer of membranes and bring about 
reorganization in the arrangement of fatty acid acyl chains, 
thereby altering the physical properties of the membrane (1, 
2, 6). Extensive structure-function studies indicate that al- 
most all such peptides tend to adopt a-helical structure in 
hydrophobic environment (2,6). The amino acid sequence of 
these peptides are such that the helix is amphiphilic in nature. 
In addition, these peptides have charged residues either flank- 
ing the amphiphilic region or present in the helical sequence. 
Their presence has been shown to be important for mem- 
brane-destabilizing activity (2, 6). 
Seminalplasmin (SPLN),’ a 47-residue peptide, present in 
bovine seminal plasma (7), is one of the few proteins isolated 
from mammalian sources, having potent antibacterial activ- 
ity. Seminalplasmin also increases the fluidity of sperm ac- 
rosomal membrane and sperm plasma membrane (8) and 
causes lysis of dividing eukaryotic cells.2 In this paper, we 
have analyzed the primary structure of SPLN (9) with respect 
to its relative hydrophobicity and hydrophilicity. We have 
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delineated a region comprising 13 amino acids, which is con- 
siderably more hydrophobic than the rest of the protein. We 
demonstrate that this hydrophobic 13-residue peptide inhibits 
growth of Escherichia coli like SPLN but also has the ability 
to lyse red blood cells which SPLN does not. 
MATERIALS AND METHODS 
Amino acids, 0-benzyl serine, y-benzyl glutamate, and PEG 600 
were from Sigma. PEG 1540, PEG 3000, and PEG 4000 were from 
Indian sources and Merrifield resin was from Vega Biotechnologies 
Inc. Side chain-protected Lys and Trp derivatives, i.e. Lys(2ClZ) and 
Trp(HC0) and a-NH*-protected Boc-amino acids were prepared by 
established procedures. Solvents and reagents were from Spectro- 
them, Bombay, India. 
Peptide Synthesis-The peptide corresponding to the sequence 
H*N-Pro-Lys-Leu-Leu-Glu-Thr-Phe-Leu-Ser-Lys-Trp-Ile-Gly- 
COOH (SPF) was synthesized by solid-phase methods, manually. 
The peptide chain was assembled on Merrifield resin (1% cross- 
linked). The coupling of the first amino acid to the resin and the 
subsequent steps were carried out essentially as described in earlier 
reports (10-12). The Boc group was employed for the protection of 
a-amino groups. The side chain protecting groups were 2 ClZ for Lys, 
OBzl for Glu, Bzl for Ser and Thr, and formyl for Trp. Cleavage of 
the peptide from the solid-support was achieved by treatment with 
trifluoroacetic acid:thioanisole:metacresol:ethanedithiol in the ratio 
(l&1:1:1, v/v) at room temperature for 12 h. After removal of the 
trifluoroacetic acid, the residue was triturated with ether to yield the 
peptide. After extensive washing with ether, the peptide was purified 
by HPLC using a Beckman Ultrapore RPMC 5-pm (4.6 X 75 mm) 
C-8 column. The purified peptide was further characterized by amino 
acid analysis on an LKB 4151 Alpha Plus amino acid analyzer and 
sequencing on an Applied Biosystems 470A protein sequencer con- 
nected to an on-line phenylthiohydantoin analyzer (model 120A). 
Stock solution of the peptide was prepared in methanol and the 
concentration determined by quantitative amino acid analysis. 
Antibacterial Actiuity-Logarithmically growing cultures of E. co& 
W160-37 (initial ATM) = 0.01) were incubated with various concentra- 
tions of SPF- and HPLC-purified seminal plasmin (9) in different 
aliquots. After 6 h, the Aw, of the culture was determined. An A,60 
value of 0.5-0.6 was observed for the control culture for which no 
peptide was added and this value was taken as 100 for the purpose of 
calculation of percentage inhibition. 
The bacteriolytic activity of SPF on E. coli was determined by 
measuring the release of @galactosidase (13) and alkaline phospha- 
tase (14). E. co/i W160-37 cells grown to log phase in minimal A 
medium (13) containing 0.4% (w/v) lactose, were incubated with the 
peptide at 37 “C. Aliquots of 150 ~1 withdrawn at different times 
diluted to 1 ml of assay buffer (0.06 M Na2HPO+ 0.04 M NaH,PO,, 
0.01 M KCI, 0.001 M MgS04, and 0.05 M mercaptoethanol, pH 7.0) 
and spun down at 12,000 X g at 4 “C. b-Galactosidase activity was 
determined in the cell-free supernatant using ONPG (13). In order 
to determine the permeability properties of the bacterial inner mem- 
brane in the presence of SPF, the influx of ONPG into the sedimented 
cells from above, was determined by incubating the cells in 1 ml of 
buffer with ONPG at 37 “C. The total enzyme activity of the sedi- 
mented cells in the absence of SPF was measured after treating the 
cells with 0.1% SDS/chloroform. Similar experiments were also per- 
formed with E. coli CSH 57, a multi-auxotrophic strain (lac y) grown 
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Synthetic Peptide Corresponding to Hydrophobic Region of Seminalplasmin 10439 
on minimal A medium supplemented with all necessary growth re- 
quirements and 5 x lo-’ isopropylthiogalactoside (13). 
For experiments on the release of alkaline phosphatase, E. coli C- 
90 strain was used and the enzyme assayed only in the supernatant. 
Lysis ofErythrocytes--Rat erythrocytes were isolated and the buffy 
coat removed by centrifugation of freshly collected blood and washing 
three times with isotonic saline. They were incubated at 37 ‘C in 10 
mM phosphate-buffered saline PBS with different concentrations of 
SPF for different time periods, centrifuged, and absorbance in the 
supernatant was measured at 540 nm. The absorbance obtained by 
treatment of erythrocytes with 1% Triton X-100 was taken as 100%. 
Osmotic Protection-Erythrocytes were suspended in 0.135 M 
NaCl, 5 mM phosphate buffer (pH 7.4) in 30 mM solution of one of 
the following substances. D-Mannitol, sucrose, raffinose, PEG of 
molecular weights 600, 1540, 3000, or 4000 (15). Then, peptide was 
added and hemolysis determined as above after incubation for 30 min 
at 37 “C. The molecular diameters of the substances used were taken 
as mannitol, 7 A; sucrose, 9 A; raffinose, 11 A; PEG 600, 16 A; PEG 
1540,24 A; PEG 3000, 30 A; and PEG 4000, 38 A (16). 
RESULTS 
The hydropathic profile of SPLN was examined by the 
method of Kyte and Doolittle (17) and the profile observed is 
shown in Fig. 1. A hydrophobic segment from residues 28 to 
40 is clearly discernible. The peptide Pro-Lys-Leu-Leu-Glu- 
Thr-Phe-Leu-Ser-Lys-Trp-Ile-Gly (SPF) corresponding to 
this region was synthesized by solid-phase methods and as- 
sayed for antibacterial and cell lytic activity. 
Antibacterial Actiuity-The percentage inhibition of the 
growth of logarithimically growing cultures of E. coli W160- 
37 on incubation with SPF and seminalplasmin at different 
concentrations is summarized in Table I. The minimal inhib- 
itory concentration of SPF is 50 Kg/ml and, in the case of 
seminalplasmin, -30 pg/ml. Antibacterial activity of SPF can 
conceivably arise due to its ability to lyse bacteria or alter the 
permeability properties of the bacterial inner membrane re- 
sulting in depolarization. Therefore, the bacteriolytic activity 
of SPF and its effect on the permeability properties of the 
-30 I , I I 
I ,O 20 30 40 
AMINO ACID RESIDUE 
FIG. 1. Hydropathic index plot of SPLN sequence. The 
SPLN sequence was analyzed by the method of Kyte and Doohttle 
(17) averaging over a range of 7 amino acids. Hydrophobic domains 
are above the dotted line and hydrophilic domains are below the dotted 
line. 
TABLE I 
Antimicrobial activity of SPF and seminalplasmin 
Compound Concentration Inhibition 
P&l % 
SPF 10 0 
20 25 
30 60 
40 90 
50 100 
Seminalplasmin 10 15 
20 95 
30 100 
bacterial inner membrane were investigated. Incubation of E. 
coli W160-37, CSH 57 (lac y), and C-90 cells with varying 
concentrations of SPF for different intervals of time and 
analysis of the cell-free supernatant did not reveal the pres- 
ence of P-galactosidase (a cytoplasmic enzyme) and alkaline 
phosphatase (a periplasmic enzyme). Therefore, SPF does not 
have the ability to lyse bacteria. The activity of ,&galactosid- 
ase in sedimented E. coli W 160-37 cells as a function of time 
and peptide concentration is shown in Fig. 2. At a peptide 
concentration of 100 pg/ml, there is a gradual increase in the 
activity of @-galactosidase until about 30 min, followed by a 
rapid rise in activity, approaching the value of the enzyme 
activity when the inner membrane of E. coli is permeabilized 
by chloroform and detergents. At a peptide concentration of 
200 rg/ml, a very rapid increase in enzyme activity is observed 
even at 30 min and the maximum activity is reached in 60 
min. The enhanced activity of P-galctosidase in sedimented 
E. coli cells in presence of SPF as compared to the control 
suggests the presence of an additional pathway for the influx 
of ONPG through the bacterial inner membrane in addition 
to the transporter protein lac permease. In order to confirm 
that SPF permeabilizes the inner membrane of E. coli, thereby 
providing an additional pathway for influx of ONPG, experi- 
ments were done in a strain which lacks lac permease. Fig. 3 
shows the activity of fi-galactosidase in sedimented E. coli 
CSH 57 (lac y) in which P-galactosidase has been induced by 
isopropylthiogalactoside in presence of SPF. Considerable @- 
galactosidase activity is detected confirming the ability of the 
peptide SPF to permeabilize the inner membrane of E. coli. 
Interaction of SPF with Red Blood Cells-Fig. 4 shows the 
hemolysis of erythrocytes as a function of the concentration 
of the peptide. Up to 6 pM, very little lysis is observed. Beyond 
6 PM, considerable lysis is observed and 100% lysis is observed 
at 30 FM. The time course of lysis of erythrocytes by the 
peptide is shown in Fig. 5. It is evident that hemolysis occurs 
gradually and is not a rapid process. In order to determine 
whether the lysis was due to a colloid-osmotic process and 
I I I 
O-Tke-i& 120 
TIME (Min.) 
FIG. 2. Effect of SPF on the influx of ONPG into E. cofi 
W160-37. A, control (no SPF); 0, 100 rg/ml SPF; and 0, 200 fig/ 
ml SPF. The cells were grown in minimal A medium containing 0.4% 
(w/v) lactose to a AsW of 0.6 and incubated with SPF at 37 “C for the 
stated period. The cells were centrifuged and the influx of ONPG 
through the inner membrane of the cells was estimated by the activity 
of @-galactosidase in the cytoplasm. Total B-galactosidase was deter- 
mined by treating the cells with 0.1% SDS/chloroform and this 
activity was taken as 100%. The values in the y axis are percentages 
of the total activity and are taken as an indicator of the influx of 
ONPG. 
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FIG. 3. Effect of SPF on the influx of ONPG into E. coli 
CSH 47 (lac y). A, control (no SPF); 0,100 pg/ml SPF; 0,200 rg/ 
ml SPF, 0, 400 pg/ml SPF. The cells were grown in minimal A 
medium with 5 X lo-” M isopropylthiogalactoside to an A600 of 0.6 
and incubated with SPF at 37 “C for the stated period. The cells were 
centrifuged and the influx of ONPG through the inner membrane of 
the cells was estimated by the activity of P-galactosidase in the 
cytoplasm. Total activity of P-galactosidase was determined as de- 
scribed in the legend for Fig. 2. The values in they axis are percentages 
of the total activity and are taken as an indicator of the influx of 
ONPG. 
PEPTIOE CONCENTRATION Cj’ Ml 
FIG. 4. Hemolysis of rat erythrocytes as a function of SPF 
concentration. Erythrocytes (0.5%, v/v) were incubated in phos- 
phate-buffered (10 mM) isotonic saline containing various concentra- 
tions of SPF for 20 min. 
also to determine the size of the membrane lesion, the he- 
molysis by the red blood cells was studied in the presence of 
peptides and various osmoprotectants. The lysis data in the 
presence of osmoprotectants is presented in Fig. 6. Protection 
against lysis is observed to some extent in the presence of 
PEG 3000 and to a large extent in the presence of PEG 4000 
indicating that the lesions produced by the peptide are 36-40 
A in diameter. The osmotic protection at various concentra- 
tions of the peptide was investigated next. The data shown in 
Fig. 7 indicates that even at a peptide concentration of 8 PM 
where -40% lysis is observed in the absence of any osmopro- 
tectant, lysis is prevented only by PEG 3000 and 4000. The 
perturbation of the red blood cell membrane did not, however, 
result in release of membrane fragments into the supernatant 
as no phospholipid was detected by lipid estimation assays, 
in the lysis experiments. The membrane-perturbing ability of 
SPF against E. coli and erythrocytes was completely abolished 
on pre-incubation of peptide with trypsin, showing that 
shorter fragments of SPF generated by trypsin do not possess 
membrane-perturbing ability. No lysis of erythrocytes was 
TIME (Min) 
FIG. 5. Hemolysis of rat erythrocytes by SPF as a function 
of time, A, 12 pM; 0, 18 pM; 0,24 PM. Experimental conditions were 
identical to that of Fig. 4 except that hemolysis was determined at 
different times of incubation with different concentrations of SPF. 
FIG. 6. SPF-induced hemolysis in the presence of various 
osmoprotectants. The erythrocytes (0.5%, v/v) were suspended in 
0.135 M NaCl, 5 mM phosphate buffer (pH 7.4), and 30 mM protectant. 
Subsequently, SPF (final concentration 30 wM) was added and he- 
molysis was determined after incubation for 30 min at 37 “C. 
observed in the presence of seminalplasmin. 
In order to gain insight into the structural basis of the 
membrane-perturbing ability of SPF, the circular dichroism 
spectrum of the peptide was examined in trifluoroethanol and 
micelles of SDS (Fig. 8). Two minima, approximately 205 and 
220 nm, and a cross-over, -200 nm, were observed. While 
percentage of a-helix, p-structure, or random structure pres- 
ent in SPF cannot be estimated due to its small size, the 
spectrum is characteristic of peptides in predominantly CX- 
helical conformation (18). The helical-wheel projection (19) 
of the peptide (Fig. 9) clearly indicates the amphiphilic nature 
of the peptide. Estimation of the hydrophobic moment yielded 
a value of 0.41. 
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PEPTIDE ( EJ M 1 
FIG. 7. Protection of hemolysis by osmoprotectants at var- 
ious concentrations of SPF. 0, PEG 600; A, PEG 1540; q , PEG 
3000; 0, PEG 4000. Assay conditions were same as in Fig. 6 except 
that the concentration of SPF was varied. 
-36 
FIG. 8. CD spectra of SPF in TFE (0) and 30 mM SDS (0). 
The concentration of the peptide was 100 pg/ml. Spectra were re- 
corded on a Jasco J-20 spectropolarimeter in a l-mm cell at 25 “C. 
[G], values are expressed as molar ellipticities. 
DISCUSSION 
The peptide corresponding to the most hydrophobic region 
of seminalplasmin, Pro-Lys-Leu-Leu-Glu-Thr-Phe-Leu-Ser- 
Lys-Trp-Ile-Gly, has antibacterial and cell lytic activity. Since 
SPF does not lyse E. coli its antibacterial activity appears to 
stem from its ability to insert into the inner membrane of E. 
coli and render it permeable to substrates like ONPG which 
cannot cross the membrane barrier without the presence of a 
protein transporter. The breakdown in the permeability bar- 
rier and the consequential depolarization of the inner mem- 
brane results in the inhibition of the growth of E. coli but not 
of their lysis. SPF, however, lysed erythrocytes. The gradual 
release of hemoglobin during lysis as well as the lysis protec- 
tion experiments indicate that a colloid-osmotic process is 
involved in hemolysis. Although SPF is comprised of only 13 
amino acid residues, circular dichroism studies indicate that 
SPF adopts an a-helical structure particularly in hydrophobic 
environment. Edmundson wheel projection indicates that the 
FIG. 9. Projection of the sequence of SPF as an a-helical 
wheel according to Schiffer and Edmundson (19). Hydrophobic 
residues are underlined. 
helix is amphiphilic in nature with a polar face comprising of 
Glu, Ser, Lys, Gly, and Thr residues and an apolar face 
comprising Ile, Pro, Leu, Trp, and Phe residues. A hydropho- 
bic moment (20) of -0.41 is obtained for SPF which is 
comparable to many of the recently reported membrane-active 
peptides (21, 22). Thus SPF is one of the very few 13-residue 
peptides having antibacterial and hemolytic activity. It thus 
appears that the length of the peptide chain and thereby the 
length of a-helix is not a crucial factor for membrane activity. 
Results reported in this paper as well as studies on the 13- 
residue peptides crabrolin (21) and bombolitin (21) and re- 
cently reported model peptides (22) indicates that juxtaposi- 
tion of the side chains in the helix (that is, the extent of 
amphilicity) is an important factor for membrane activity. 
The gradual release of hemoglobin and the lysis protection 
experiments also argue against a mechanism of lysis involving 
solubilization of the membrane by a detergent-like action of 
:he peptide. Lysis protection experiments indicate pores of 40 
A. Unlike in the case of hemolysis induced by gramicidins 
and melittin (15) the size of the lesion seems independent of 
the peptide concentration. It therefore seems possible that 
SPF aggregates in the membrane phase to form hydrophilic 
channels, in spite of its short length. A 13-residue NH,- 
terminal fragment of alamethicin has been shown to be active 
in ion transport and uncoupling oxidative phosphorylation in 
mitochondria (23-25). 
The peptide SPF corresponds to the single hydrophobic 
domain in seminal plasmin. The membrane-perturbing ability 
of SPF was examined with a view to evaluate the importance 
of this region in the antibacterial and eukaryotic cell lytic 
activity of SPLN (26). The peptide has bacteriostatic activity 
but does not lyse bacterial cells, whereas SPLN has both 
bacteriostatic and bacteriolytic activity. SPF exhibits lytic 
activity against erythrocytes and dividing cells, whereas 
SPLN specifically lyses only dividing cells. However prelimi- 
nary observations indicate that SPF, like SPLN, increases 
the fluidity of sperm plasma membrane. While regions other 
than the sequence corresponding to SPF clearly modulate the 
antibacterial and selective eukaryotic cell lytic activity of 
SPLN, we propose that the sequence corresponding to SPF 
is primarily responsible for the membrane-perturbing ability 
of SPLN. Evaluation of the biological activity of analogs of 
SPLN without the SPF sequence or with variants of this 
sequence would help in confirming our hypothesis. Studies 
directed toward this end are currently in progress. 
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